首页> 外文期刊>Drugs of today: Medicamentos de actualidad >Primary prevention by early intervention with specific immunotherapy.
【24h】

Primary prevention by early intervention with specific immunotherapy.

机译:利用特定免疫疗法提前干预初步预防。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of prospective birth cohort studies performed in Australia, Europe and the USA have shown that persistent allergic sensitization is most commonly initiated during the first few years of life. In light of the wide-ranging experimental literature demonstrating that the plasticity of T helper (Th) cell memory is inversely related to the longevity of individual immune responses, the preschool years are becoming an increasingly attractive target for immune interventions aimed at primary and also secondary prevention of sensitization. Earlier studies, now replicated by many labs internationally, have implicated maturational deficiencies in adaptive and innate immune functions as risk factors in this sensitization process.
机译:在澳大利亚,欧洲和美国进行的一系列前瞻性队列研究表明,在生命的前几年中,持续过敏性敏感性最为常见。 根据广泛的实验文献,表明T辅助者(TH)细胞记忆的可塑性与个体免疫反应的寿命反向相关,学龄前是对旨在的免疫干预措施越来越有吸引力的目标目标 预防敏感。 早期的研究现在通过国际知名度的许多实验室复制,在适应性和先天的免疫功能中暗示了适应性和先天免疫功能的成熟缺陷,作为这种敏感过程的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号